Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.

A 43-year-old man presented with simultaneously occurring alopecia areata and stage IIIB nodular sclerosing Hodgkin's disease. Systemic symptoms of Hodgkin's disease were present for 6 months, and rapidly developing patchy hair loss of the scalp was present for 2 weeks prior to presentation. The patient was treated with eight cycles of MOPP-ABV chemotherapy that resulted in complete remission of Hodgkin's-disease. Four months after the completion of chemotherapy, the patient had normal hair regrowth with no evidence of alopecia areata. Alopecia areata may be an autoimmune disease and may respond to chemotherapy.
AuthorsP D Chan, M A Berk, O Kucuk, S Singh
JournalMedical and pediatric oncology (Med Pediatr Oncol) Vol. 20 Issue 4 Pg. 345-8 ( 1992) ISSN: 0098-1532 [Print] UNITED STATES
PMID1376855 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bleomycin
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Vinblastine
  • Doxorubicin
  • Prednisone
  • Adult
  • Alopecia Areata (drug therapy, etiology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Autoimmune Diseases (complications, drug therapy)
  • Bleomycin (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Hodgkin Disease (complications, drug therapy, pathology)
  • Humans
  • Male
  • Mechlorethamine (administration & dosage)
  • Neoplasm Staging
  • Prednisone (administration & dosage)
  • Procarbazine (administration & dosage)
  • Remission Induction
  • Vinblastine (administration & dosage)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: